Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
11.68
+0.29 (2.55%)
Apr 8, 2026, 3:04 PM CST

SHE:002399 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,3461,4221,7662,1392,944
Short-Term Investments
-387.17206.2--
Trading Asset Securities
1,484867.9414.181,312981.16
Cash & Short-Term Investments
2,8302,6772,3863,4503,925
Cash Growth
5.72%12.19%-30.85%-12.10%8.59%
Accounts Receivable
1,3681,1871,2751,6261,543
Other Receivables
38.49173.3121.89134.82243.81
Receivables
1,4061,3601,3961,7611,787
Inventory
4,4475,3946,6546,8444,708
Prepaid Expenses
-123.18111.28--
Other Current Assets
468.1567.1556.43334.53349.43
Total Current Assets
9,1519,62110,60412,39010,770
Property, Plant & Equipment
2,3882,8542,8492,4772,537
Long-Term Investments
1,7661,8232,5142,4642,618
Goodwill
2,3052,3572,3222,3512,152
Other Intangible Assets
326.57301.57370.78522.87546.87
Long-Term Deferred Tax Assets
320.44282.51320.5141.48121.72
Long-Term Deferred Charges
178.965.118.64244.71241.88
Other Long-Term Assets
195.3298.61203.87224.95120.85
Total Assets
16,63217,34419,20320,81619,108
Accounts Payable
257.07299.69306.34427.43385.79
Accrued Expenses
138.06393.1388377.51398.43
Short-Term Debt
1,7708441,0692,3851,886
Current Portion of Long-Term Debt
864.71,5232,5561,6351,382
Current Portion of Leases
-38.8237.835.6931.75
Current Income Taxes Payable
149.06120.26157.18112.3113.2
Current Unearned Revenue
227.6264.28362.05433.88383.79
Other Current Liabilities
546.43215.92110.24168.2210.34
Total Current Liabilities
3,9533,6994,9865,5764,791
Long-Term Debt
298.061,0811,8102,2972,250
Long-Term Leases
40.3257.7790.42110.75104
Long-Term Unearned Revenue
42.5827.2930.4332.5516.67
Pension & Post-Retirement Benefits
-23.2235.2732.49120.65
Long-Term Deferred Tax Liabilities
207.07242.49252.57328.92275.36
Other Long-Term Liabilities
10.1910.3510.1529.3926.44
Total Liabilities
4,5525,1417,2158,4077,585
Common Stock
1,4671,4671,4671,4671,467
Additional Paid-In Capital
5,8647,5297,5295,8595,944
Retained Earnings
4,5664,5883,9414,8614,184
Comprehensive Income & Other
133.96-1,436-1,024125.52-183.36
Total Common Equity
12,03112,14911,91312,31311,411
Minority Interest
49.2353.4575.2396.72111.96
Shareholders' Equity
12,08012,20211,98812,40911,523
Total Liabilities & Equity
16,63217,34419,20320,81619,108
Total Debt
2,9743,5455,5636,4645,654
Net Cash (Debt)
-143.41-867.91-3,177-3,013-1,729
Net Cash Per Share
-0.10-0.59-2.15-2.05-1.18
Filing Date Shares Outstanding
1,4671,4671,4671,4671,467
Total Common Shares Outstanding
1,4671,4671,4671,4671,467
Working Capital
5,1985,9225,6186,8145,978
Book Value Per Share
8.208.288.128.397.78
Tangible Book Value
9,4009,4909,2209,4398,712
Tangible Book Value Per Share
6.416.476.286.435.94
Land
-34.513433.4330.61
Buildings
-1,9311,9151,4801,450
Machinery
-2,0071,9611,8921,719
Construction In Progress
-697.77468.72394.53425.35
Leasehold Improvements
-15.7315.43--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.